Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Classifica tra le azioni #32134
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Prezzo delle azioni
$1.49
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$10.94M
Variazione (1 giorno)
4.58%
Variazione (1 anno)
-55.67%
Paese
US
Scambia Ainos, Inc. (AIMD)

Categoria

Storico del rendimento da dividendi per Ainos, Inc. (AIMD)
Il rendimento da dividendi (TTM) di Ainos, Inc. (simbolo azionario: AIMD) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Ainos, Inc. (AIMD) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
KR